Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Memory Pharmaceuticals Corp. (NASDAQ:MEMY.DL)

CAPS Rating: No stars

A biopharmaceutical company focuses on the discovery and development of innovative drug candidates for the treatment of a range of central nervous system conditions.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MEMY.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NetscribeHealthC (76.25)
Submitted February 22, 2007

Memory is a biopharmaceutical company focused in the discovery and development of drugs for the treatment of a range of central nervous system (CNS) conditions. These conditions include neurological diseases associated with aging, such as Alzheimer's… More

atomfenrir (65.31)
Submitted July 01, 2007

Terrible fundamentals. Am I missing something here?

NASDAQ:MEMY.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about MEMY.DL.

No one has written a Pitch for MEMY.DL stock yet. Tell us why you think MEMY.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in MEMY.DL.

No players have picked MEMY.DL yet. Tell us why you think MEMY.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MEMY.DL.